These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16308211)

  • 1. Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice.
    Khan MA; Owais M
    J Drug Target; 2005 Aug; 13(7):423-9. PubMed ID: 16308211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    Khan MA; Nasti TH; Owais M
    J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
    Khan MA; Aljarbou A; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):88-97. PubMed ID: 22612788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B.
    Khan MA; Ahmad N; Moin S; Mannan A; Wajahul H; Pasha ST; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):269-76. PubMed ID: 15907448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis.
    Masood AK; Faisal SM; Haque W; Owais M
    J Drug Target; 2002 May; 10(3):185-92. PubMed ID: 12075819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B.
    Khan MA; Syed FM; Nasti HT; Saima Dagger K; Haq W; Shehbaz A; Owais M
    J Drug Target; 2003 Feb; 11(2):93-9. PubMed ID: 12881195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model.
    Khan MA; Faisal SM; Mohammad O
    J Drug Target; 2006 May; 14(4):233-41. PubMed ID: 16777682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.
    Fries BC; Cook E; Wang X; Casadevall A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):350-7. PubMed ID: 15616315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans.
    Hossain MA; Maesaki S; Kakeya H; Noda T; Yanagihara K; Sasaki E; Hirakata Y; Tomono K; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1722-5. PubMed ID: 9661011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
    Silva EG; Paula CR; Dias AL; Chang MR; Ruiz Lda S; Gambale V; Prates RA; Ribeiro MS
    Mycopathologia; 2011 Apr; 171(4):261-6. PubMed ID: 20972836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.
    Sangalli-Leite F; Scorzoni L; Alves de Paula E Silva AC; da Silva JF; de Oliveira HC; de Lacorte Singulani J; Gullo FP; Moraes da Silva R; Regasini LO; Siqueira da Silva DH; da Silva Bolzani V; Fusco-Almeida AM; Soares Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Nov; 48(5):504-511. PubMed ID: 27742203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis.
    Owais M; Ahmed I; Krishnakumar B; Jain RK; Bachhawat BK; Gupta CM
    FEBS Lett; 1993 Jul; 326(1-3):56-8. PubMed ID: 8325389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
    Block ER; Bennett JE
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):476-80. PubMed ID: 4570039
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of experimental murine cryptococcosis: a comparison of miconazole and amphotericin B.
    Graybill JR; Mitchell L; Levine HB
    Antimicrob Agents Chemother; 1978 Feb; 13(2):277-83. PubMed ID: 348099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effect of voriconazole on the production of proinflammatory cytokines in experimental cryptococcosis in mice with severe combined immunodeficiency.
    Gonçalves Silva E; Marilia de Souza Silva S; Rodrigues Paula C; da Silva Ruiz L; Latercia Tranches Dias A
    J Mycol Med; 2018 Mar; 28(1):106-111. PubMed ID: 29273275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.